| Date Filed | Type | Description |
| 06/16/2023 |
4
| Collins Cynthia (Director) has filed a Form 4 on Poseida Therapeutics, Inc.|
Txns:
| Granted 19,650 shares
@ $0
Granted 27,350 options to buy
@ $2.47, valued at
$67.6k
|
|
| 06/05/2023 |
4
| Collins Cynthia (Director) has filed a Form 4 on DermTech, Inc.|
Txns:
| Granted 35,714 shares
@ $0 |
|
| 05/25/2023 |
4
| Collins Cynthia (Director) has filed a Form 4 on Certara, Inc.|
Txns:
| Granted 8,663 restricted stock units
@ $0 |
|
| 05/19/2023 |
4
| Collins Cynthia (Director) has filed a Form 4 on Certara, Inc.|
Txns:
| Exercised 9,067 restricted stock units
@ $0 |
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/03/2021 |
4
| Collins Cynthia (Director) has filed a Form 4 on Certara, Inc.|
Txns:
| Granted 6,431 shares
@ $0 |
|
| 08/02/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/26/2021 |
4
| Collins Cynthia (Director) has filed a Form 4 on Poseida Therapeutics, Inc.|
Txns:
| Granted 87,440 options to buy
@ $8.63, valued at
$754.6k
|
|
| 07/26/2021 |
3
| Collins Cynthia (Director) has filed a Form 3 on Poseida Therapeutics, Inc. |
| 05/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2021 |
4
| Collins Cynthia (CEO) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Sold 1,262 shares
@ $66.65, valued at
$84.1k
|
|
| 08/21/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2020 |
4
| Collins Cynthia (Director) has filed a Form 4 on DermTech, Inc.|
Txns:
| Granted 6,000 shares
@ $0 |
|
| 01/03/2020 |
4
| Collins Cynthia (Director) has filed a Form 4 on DermTech, Inc.|
Txns:
| Exercised 8,755 restricted stock units
@ $0 |
|
| 09/13/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/09/2019 |
3
| Collins Cynthia (Director) has filed a Form 3 on DermTech, Inc. |
| 08/21/2019 |
4
| Collins Cynthia (CEO) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Granted 8,283 shares
@ $0
Sold 5,193 shares
@ $25.83, valued at
$134.1k
|
|
| 08/07/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2019 |
4
| Collins Cynthia (Interim CEO) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Granted 11,538 options to buy
@ $21.74, valued at
$250.8k
|
|
| 02/04/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/10/2018 |
4
| Collins Cynthia (Director) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Granted 23,076 options to buy
@ $29.69, valued at
$685.1k
|
|
| 12/10/2018 |
3
| Collins Cynthia (Director) has filed a Form 3 on Editas Medicine, Inc. |
| 01/24/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/25/2012 |
4
| Collins Cynthia (President & CEO) has filed a Form 4 on GENVEC INC|
Txns:
| Granted 250,000 options to buy
@ $2.54, valued at
$635k
|
|
| 05/25/2012 |
3
| Collins Cynthia (President & CEO) has filed a Form 3 on GENVEC INC |
| 07/05/2011 |
4
| Collins Cynthia (Group Vice President) has filed a Form 4 on BECKMAN COULTER INC|
Txns:
| Granted 4,430 shares
@ $0
Disposed/sold 15,043 shares
@ $83.5, valued at
$1.3M
Disposed/sold 52 shares
@ $83.5, valued at
$4.4k
Disposed/sold 20,000 options to buy
@ $66.04, valued at
$1.3M
Disposed/sold 9,600 options to buy
@ $72.49, valued at
$695.9k
Disposed/sold 16,560 options to buy
@ $43.32, valued at
$717.4k
Disposed/sold 12,750 options to buy
@ $67.88, valued at
$865.5k
Disposed/sold 9,310 options to buy
@ $76.04, valued at
$707.9k
Disposed/sold 403 options to buy
@ $83.5, valued at
$33.6k
|
|
| 06/28/2011 |
4
| Collins Cynthia (Group Vice President) has filed a Form 4 on BECKMAN COULTER INC|
Txns:
| Unknown transaction of 8,552 shares
@ $83.5, valued at
$714.1k
|
|
| 03/07/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/10/2011 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities |
| 01/11/2011 |
4
| Collins Cynthia (Group Vice President) has filed a Form 4 on BECKMAN COULTER INC|
Txns:
| Paid exercise price by delivering 283 shares
@ $73.87, valued at
$20.9k
|
|
|